A leader with over 25 years of experience in biotechnology and pharmaceuticals, specializing in drug discovery, translational biology, and stem cell therapeutics. He currently serves as the Director of Translational Biology at the Broad Institute, leveraging his Ph. D. from Baylor College of Medicine and postdoctoral work at Stanford University to advance novel therapies.
He shows a strong interest in supporting and connecting innovators, whether in data science or creative fields. His social media activity indicates he is a vocal supporter of Studio Guicherit, an architectural design firm, suggesting an appreciation for design and entrepreneurship.
He is an outspoken advocate for Phenotypic Screening as a powerful method for drug discovery.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.